Find a Doctor or Practice Location

Autoimmune skin disease
Cutaneous Lupus Erythematosus
Dermatomyositis
Pemphigus vulgaris

Medical School: Johns Hopkins University School of Medicine
Residency: Northwestern Medical Center
Residency: New York University Medical Center

American Academy of Dermatology Program for Dermatology for the 21st Century, National American Academy of Dermatology, member, National American College of Physicians, American College of Rheumatology, Canadian Dermatology Society, National Committee on Government and Public Relations. Society of Investigative Dermatology (2002-), Data Safety Monitoring Board for High Dose Immunoblative Cytoxan for Lupus Erythematosus (Michelle Petri, Johns Hopkins), 1999-present, Dermatology Field Advisory Committee,(reports to Central Office, VA), National Dermatology Foundation, Dermatology Study group Co-Chair (1999) National Association of V.A. Dermatologists, Secretary-, FOCIS Abstract Review Committee, National Leaders Society Campaign for the Dermatology Foundation, National Lupus Foundation of America, National Lupus Foundation of Delaware Valley (1998-), Local Lupus Research Institute, Local Medical Advisory Board, Dermatomyositis support group, Arthritis Foundation (Pennsylvania), 2002-, Medical Advisory Board, International Inflammatory Myositis Foundation, International Medical Advisory Board, National Pemphigus Foundation (1997-), National Medical Advisory Board, Scleroderma Foundation, 2002-, National Medical Dermatology Society, Myositis Criteria Study, International National Association of Rheumatologic Dermatology Society, National National Association of VA Dermatologists, National NIH Autoimmune Centers of Excellence, National NIH Meeting on Pemphigus, National NIH/NIAMS Study Section (AMS), National Pennsylvania Academy of Dermatology, Philadelphia College of Physicians, Philadelphia Dermatology Society, Local Skin Rheumatism and Autoimmunity, International Society of Investigative Dermatology, National Society of Investigative Dermatology, National Symposium on Scoring Systems in Dermatology, World Congress of Dermatology, International

Hospital Privileges:

• Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
• Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Description of Research Expertise:

Photobiology
Tumor necrosis factor
Cutaneous lupus
Glycosaminoglycans
Clinical and translational research in cutaneous autoimmune diseases

Selected Publications:

Orbai AM1, Truedsson L2, Sturfelt G3, Nived O3, Fang H1, Alarcón GS4, Gordon C5, Merrill J6, Fortin PR7, Bruce IN8, Isenberg DA9, Wallace DJ10, Ramsey-Goldman R11, Bae SC12, Hanly JG13, Sanchez-Guerrero J14, Clarke AE15, Aranow CB16, Manzi S17, Urowitz MB18, Gladman DD18, Kalunian KC19, Costner MI20, Werth VP21, Zoma A22, Bernatsky S15, Ruiz-Irastorza G23, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, Van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ,: Anti-C1q antibodies in systemic lupus erythematosus Lupus 24 (1): 42-9,2015.

Merola JF, Nyberg P, Furukawa F, Goodfield MJ, Hasegawa M, Marinovic B, Szepietowski JC, Dutz J, Werth VP: Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaire Lupus Science & Medicine 2 (1): 2015.

Robinson ES, Feng R, Okawa J, Werth VP: Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of life Br J Dermatol 172 (1): 169-74,2015.

Murrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP, Woodley D, Zone J, Aoki V, Bernard P, Bruckner-Tuderman L, Cianchini G, Venning V, Diaz L, Eming R, Grando SA, Hall RP, Hashimoto T, Herrero-González JE, Hertl M, Joly P, Karpati S, Kim J, Chan Kim S, Korman NJ, Kowalewski C, Lee SE, Rubenstein DR, Sprecher E, Yancey K, Zambruno G, Zillikens D, Doan S, Daniel BS, Werth VP: Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts J Am Acad Dermatol 72 (1): 168-74,2015.

Schultz HY, Dutz JP, Furukawa F, Goodfield M, Kuhn A, Lee LA, Nyberg F, Szepietowski JC, Sontheimer RD, Werth VP: From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and novel treatments of cutaneous lupus erythematosus and dermatomyositis: A report from the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013 J Invest Dermatol 135 (1): 7-12,2015.

Shah AA Seiffert-Sinha K, Sirois D, Werth VP, Zrnchik W, Sinha AA: Development of a disease registry for autoimmune bullous diseases: initial analysis for the Pemphigus vulgaris subset Acta Dermato-Venereologica 95 (1): 86-90,2015.

Micheletti RG, Werth VP: Small vessel vasculitis of the skin Rheum Dis Clin North Am 41 (1): 21-32,2015.

Shimizu T, Takebayashi T, Sato Y, Niizeki H, Aoyama Y, Kitajima Y, Iwatsuki K, Hashimoto T, Yamagami J, Werth VP, Amagai M, Tanikawa A: Grading criteria for disease severity by pemphigus disease area index J Dermatol 41 (11): 969-73,2014.

Anyanwu CO, Stewart CL, Werth VP: Thalidomide-induced Orofacial Neuropathy J Clin Rheumatol 20 (7): 399-400,2014.

Korgavkar K, Firoz EF, Xiong M, Lew R, Marcolivio K, Burnside N, Dyer R, Weinstock MA; VAKCC Trial Group (includes Werth VP): Measuring the severity of topical 5-fluorouracil toxicity J Cutan Med Surg. 18 (4): 229-35,2014.

The Myositis Association

Penn Dermatology website

Philadelphia Dermatology Society

Lupus Foundation of America

Lupus Research Institute

Medical Dermatology Society

The Myositis Association

Pennsylvania Academy of Dermatology

International Pemphigus and Pemphigoid Foundation

Scleroderma Foundation